Virulence Factor Cargo and Host Cell Interactions of Shiga Toxin-Producing Escherichia coli Outer Membrane Vesicles.

[1]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli O157 outer membrane vesicles induce interleukin 8 production in human intestinal epithelial cells by signaling via Toll-like receptors TLR4 and TLR5 and activation of the nuclear factor NF-κB. , 2018, International journal of medical microbiology : IJMM.

[2]  A. Jan.  Outer Membrane Vesicles (OMVs) of Gram-negative Bacteria: A Perspective Update , 2017, Front. Microbiol..

[3]  J. A. Ibarra,et al.  The outer membrane vesicles: Secretion system type zero , 2017, Traffic.

[4]  S. Loos,et al.  Haemolytic uraemic syndrome , 2017, Journal of internal medicine.

[5]  A. Mellmann,et al.  Host cell interactions of outer membrane vesicle-associated virulence factors of enterohemorrhagic Escherichia coli O157: Intracellular delivery, trafficking and mechanisms of cell injury , 2017, PLoS Pathogens.

[6]  M. Kuehn,et al.  Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions , 2015, Nature Reviews Microbiology.

[7]  Björn Kemper,et al.  Virulence from vesicles: Novel mechanisms of host cell injury by Escherichia coli O104:H4 outbreak strain , 2015, Scientific Reports.

[8]  Angela R Melton-Celsa,et al.  Shiga Toxin (Stx) Classification, Structure, and Function , 2014, Microbiology spectrum.

[9]  A. Mellmann,et al.  Enterohemorrhagic Escherichia coli Hemolysin Employs Outer Membrane Vesicles to Target Mitochondria and Cause Endothelial and Epithelial Apoptosis , 2013, PLoS pathogens.

[10]  R. Mandrell,et al.  A Polyclonal Antibody Based Immunoassay Detects Seven Subtypes of Shiga Toxin 2 Produced by Escherichia coli in Human and Environmental Samples , 2013, PloS one.

[11]  Lassi Paavolainen,et al.  BioImageXD: an open, general-purpose and high-throughput image-processing platform , 2012, Nature Methods.

[12]  T. Obrig.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease , 2010, Toxins.

[13]  M. Morigi,et al.  Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction , 2010, Pediatric Nephrology.

[14]  M. Kuehn,et al.  Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.

[15]  H. Karch,et al.  Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin , 2009, Molecular microbiology.

[16]  A. Friedrich,et al.  Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. , 2007, Microbes and infection.

[17]  A. Friedrich,et al.  Cytolethal Distending Toxin in Escherichia coli O157:H7: Spectrum of Conservation, Structure, and Endothelial Toxicity , 2006, Journal of Clinical Microbiology.

[18]  H. Karch,et al.  Enterohaemorrhagic Escherichia coli in human medicine. , 2005, International journal of medical microbiology : IJMM.

[19]  H. Karch,et al.  Cytolethal Distending Toxin from Shiga Toxin-Producing Escherichia coli O157 Causes Irreversible G2/M Arrest, Inhibition of Proliferation, and Death of Human Endothelial Cells , 2005, Infection and Immunity.

[20]  H. Karch,et al.  Cytolethal Distending Toxin Gene Cluster in Enterohemorrhagic Escherichiacoli O157:H− and O157:H7: Characterization and Evolutionary Considerations , 2003, Infection and Immunity.

[21]  R. Lloubès,et al.  Pal Lipoprotein of Escherichia coli Plays a Major Role in Outer Membrane Integrity , 2002, Journal of bacteriology.

[22]  K. Yokoyama,et al.  Production of shiga toxin by Escherichia coli measured with reference to the membrane vesicle-associated toxins. , 2000, FEMS microbiology letters.

[23]  Glynis L. Kolling,et al.  Export of Virulence Genes and Shiga Toxin by Membrane Vesicles of Escherichia coli O157:H7 , 1999, Applied and Environmental Microbiology.

[24]  F. Gilles,et al.  Selective expression of adhesion molecules on human brain microvascular endothelial cells , 1997, Journal of Neuroimmunology.

[25]  J. Slot,et al.  Improving structural integrity of cryosections for immunogold labeling , 1996, Histochemistry and Cell Biology.

[26]  L. Beutin,et al.  Molecular analysis of the plasmid-encoded hemolysin of Escherichia coli O157:H7 strain EDL 933 , 1995, Infection and immunity.

[27]  Dr. Gareth Griffiths.  Fine Structure Immunocytochemistry , 1993, Springer Berlin Heidelberg.

[28]  L. Becker,et al.  The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. , 1988, Human pathology.

[29]  S. Johansson,et al.  The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. , 1987, Journal of immunological methods.

[30]  K. Tokuyasu.  Immunochemistry on ultrathin frozen sections , 1980, The Histochemical Journal.

[31]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[32]  K. Tokuyasu.  A TECHNIQUE FOR ULTRACRYOTOMY OF CELL SUSPENSIONS AND TISSUES , 1973, The Journal of cell biology.

[33]  H. Karch,et al.  Non-O157:H7 pathogenic Shiga toxin-producing Escherichia coli: phenotypic and genetic profiling of virulence traits and evidence for clonality. , 1999, The Journal of infectious diseases.